Trump proposes 200% medicine tariffs
The Arab.net newspaper reported that U.S. President Donald Trump intends to impose a 200% tariff on imported medicines starting from mid-2028, in an effort to encourage pharmaceutical companies to manufacture them within the United States. Alternative medications will remain exempt from tariffs until August 2028, after which a 100% duty will be applied for one year before increasing to 200%. Pharmaceutical companies will be granted a two-year grace period to shift production to the U.S., with expectations of imposing penalties on those that choose not to comply, although no details or legal basis for the decision have been specified. This move is part of pressure measures on pharmaceutical companies that produce outside the United States.
Notice: This Is an AI-Generated Summary
Comments (0)